UBC Faculty Research and Publications

What is the Common Drug Review? Therapeutics Initiative (University of British Columbia)

Description

Therapeutics Letter 61 outlines the Common Drug Review (CDR) process in Canada and uses examples from four drug reviews. The Common Drug Review is a standardized process whereby the relative therapeutic and cost effectiveness of new brand name drugs is reviewed for government drug plans across Canada. The full drug reviews are used by CEDAC to develop listing recommendations and rationales for the recommendations, available on the CDR website: www.cadth.ca/index.php/en/cdr. At the present time full drug reviews are not open to the public.

Item Citations and Data

Rights

Attribution-NonCommercial-NoDerivatives 4.0 International